Experimental techniques for the diagnosis and treatment of common diseases form the practical backbone of clinical medicine and medical education, combining laboratory diagnostics, physiological monitoring, and hands-on therapeutic procedures. This article offers a comprehensive technical overview of the specimen types, testing items, validated experimental methods, and international standards—such as ISO 15189, IEC 60601, and CLSI guidelines—that govern these experiments in teaching laboratories, hospitals, and accredited third-party laboratories.
Technical Overview
Common disease diagnosis and treatment technology experiments encompass a structured set of laboratory and clinical skills exercises designed to validate the accuracy of diagnostic measurements and the competency of therapeutic procedures for frequently encountered conditions. These conditions typically include hypertension, diabetes mellitus, acute respiratory infections, gastrointestinal disorders, anemia, and coronary artery disease. The experimental system integrates three domains: physiological measurement (vital signs, electrocardiography, spirometry), clinical laboratory analysis (hematology, clinical chemistry, urinalysis, and microbiology), and therapeutic technique training (injection, intravenous infusion, catheterization, nebulization, airway management, and wound care).
All experimental procedures should be performed under a recognized quality framework. Medical laboratories are generally accredited to ISO 15189 (Medical laboratories—Requirements for quality and competence), while diagnostic instruments must conform to the IEC 60601 series for medical electrical equipment and relevant ISO performance standards. In vitro diagnostic reagents are governed by ISO 13485 quality management requirements, and laboratory biosafety follows the WHO Laboratory Biosafety Manual together with applicable GB national standards for clinical laboratory technology.
Testing Samples
The experimental system operates on two categories of test subjects: biological specimens obtained for diagnostic analysis and simulation platforms used for procedural technique validation.
Blood Specimens
Venous and capillary blood samples are collected for complete blood count, fasting plasma glucose, glycated hemoglobin (HbA1c), lipid profile, and liver and kidney function panels. Venipuncture technique, anticoagulant selection, and sample handling directly influence result validity, making pre-analytical control a core learning objective.
Urine Specimens
Midstream clean-catch urine is used for physical, chemical, and microscopic urinalysis, supporting the diagnosis of urinary tract infections, diabetes, and renal disease. First-morning specimens are preferred for maximum analyte concentration.
Respiratory and Throat Specimens
Sputum samples and throat swabs are processed for Gram staining, culture, and antimicrobial susceptibility testing in accordance with CLSI microbiology guidelines, supporting the diagnosis of community-acquired pneumonia, influenza-like illness, and streptococcal pharyngitis.
Stool Specimens
Fecal samples are examined macroscopically, microscopically, and by immunoassay for occult blood and enteric pathogens, assisting in the evaluation of gastroenteritis, parasitic infection, and colorectal disease screening.
Simulation Models and Standardized Patients
Full-body and task-trainer manikins, arm models for venipuncture, and standardized human simulators are used to validate therapeutic techniques such as intramuscular injection, urinary catheterization, and basic life support without risk to real patients.
Testing Items
The experiment portfolio covers diagnostic measurement items and therapeutic procedure items, each with defined acceptance criteria:
- Vital signs measurement: blood pressure by auscultatory and oscillometric methods, body temperature, radial pulse, respiratory rate, and peripheral oxygen saturation (SpO2).
- Electrocardiography: standard 12-lead ECG recording and recognition of common arrhythmias, atrial fibrillation, and ischemic patterns.
- Pulmonary function testing: peak expiratory flow and spirometric parameters for asthma and chronic obstructive pulmonary disease assessment.
- Hematology: hemoglobin, red cell and white cell counts, platelet count, and blood smear morphology for anemia and infection evaluation.
- Clinical chemistry: fasting glucose, HbA1c, total cholesterol, triglycerides, creatinine, urea, and hepatic enzymes.
- Urinalysis: pH, specific gravity, protein, glucose, ketones, nitrites, leukocyte esterase, and urine sediment microscopy.
- Microbiology: bacterial culture, colony identification, and disk-diffusion antimicrobial susceptibility testing.
- Therapeutic techniques: aseptic hand hygiene and gloving, subcutaneous and intramuscular injection, intravenous cannulation and infusion, oxygen therapy and nebulization, nasogastric and urinary catheterization, wound dressing, and cardiopulmonary resuscitation.
Testing Methods
Each diagnostic item is performed by a documented reference or routine method with embedded quality control. Blood pressure measurement follows the auscultatory reference procedure and oscillometric device validation aligned with ISO 81060-2. Pulse oximeters are evaluated against the performance requirements of ISO 80601-2-61, and blood glucose monitoring systems are verified per ISO 15197. ECG machines are tested to IEC 60601-2-25 electrical safety and performance requirements as part of the IEC 60601-1 general standard family.
Laboratory assays employ calibrated automated analyzers, commercial control materials at two or more concentration levels, and participation in external quality assessment schemes consistent with ISO 15189. Microbiological work, including staining, culture media QC, and susceptibility testing, follows CLSI reference methods. Therapeutic technique experiments are assessed using objective structured clinical examination (OSCE) checklists, with manikin-based metrics such as compression depth and rate for CPR recorded by instrumented feedback devices.
- Pre-analytical phase: patient identification, specimen labeling, collection technique, transport time, and rejection criteria.
- Analytical phase: instrument calibration, internal quality control, duplicate testing, and method verification for precision and trueness.
- Post-analytical phase: result review, critical value reporting, and clinical interpretation linking findings to common disease diagnostic criteria.
- Biosafety controls: risk-group-appropriate containment, personal protective equipment, sharps management, and disinfection per the WHO biosafety framework and applicable GB laboratory safety standards.
Applications
These experiments are applied across medical and nursing education, postgraduate clinical training, and device performance validation. Teaching hospitals use them to build diagnostic reasoning and procedural competence before supervised patient contact. Simulation centers deploy them for skill certification and remediation. Accredited third-party laboratories and manufacturers apply the same methods to verify diagnostic device performance against ISO and IEC standards prior to market release. Primary healthcare programs use simplified versions of the measurement items for community screening of hypertension and diabetes, while public health institutions rely on the microbiological modules for surveillance of respiratory and enteric infections. The experimental framework also supports standardized OSCE examinations and licensure assessment of clinical skills.
FAQ
What is the purpose of common disease diagnosis and treatment technology experiments? The purpose is to validate the accuracy and reliability of diagnostic measurements, and to establish hands-on competence in therapeutic procedures, under controlled laboratory conditions before clinical application.
Which standards govern these experiments? Laboratory quality is governed by ISO 15189, diagnostic instruments by the IEC 60601 series and associated ISO performance standards such as ISO 81060-2, ISO 80601-2-61, and ISO 15197, and microbiology methods by CLSI guidelines, supplemented by WHO biosafety recommendations and applicable GB national standards.
How is experimental accuracy ensured? Accuracy is ensured through calibrated equipment, multi-level internal quality control, external quality assessment participation, standardized operating procedures, and predefined acceptance criteria for both measurement and procedural items.
Can these experiments replace clinical practice? No. They provide a controlled, low-risk environment for skill acquisition and method validation, but supervised clinical practice remains essential for full professional competency.
Are simulation models acceptable for technique assessment? Yes. Instrumented manikins and task trainers are widely accepted for OSCE-based assessment because they provide objective, repeatable metrics such as injection site accuracy, catheter placement success, and CPR compression quality.